Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ALPA | NSE
-0.28
-0.24%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
19/09/2024
114.72
116.80
118.29
112.52
Alpa Laboratories Limited engages in manufacturing and selling pharmaceutical finished dosage forms in India. It offers ethical generic and over the counter products in various finished dosage forms including injections tablets capsules eye and ear drops ointments creams and gels for human use. The company also provides boluses injections and intra-mammary infusions for veterinary use. In addition the company provides drugs in various categories such as anti-infectives comprising antibacterial antibiotics antifungals antiprotozoals and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations as well as ear and eye care preparations. It sells its products through distributors retail chemists retail pharmacy stores and hospitals. The company also exports its products to South and Central America Africa and Asia and CIS countries. Alpa Laboratories Limited was founded in 1967 and is based in Indore India.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
92.5%1 month
69.0%3 months
50.7%6 months
46.6%14.11
-
1.70
0.03
0.03
7.44
1.58
-
77.45M
2.48B
29.70M
-
-0.06
68.10
-15.70
11.71
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
24.40
Range1M
26.85
Range3M
45.45
Rel. volume
0.33
Price X volume
17.63M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Vaishali Pharma Limited | VAISHALI | Drug Manufacturers-Specialty & Generic | 192.25 | 2.06B | -1.98% | 333.23 | 31.49% |
Mangalam Drugs & Organics Limited | MANGALAM | Drug Manufacturers-Specialty & Generic | 127.32 | 2.02B | -6.02% | n/a | 72.53% |
Bal Pharma Limited | BALPHARMA | Drug Manufacturers-Specialty & Generic | 127.24 | 2.01B | -3.31% | 27.01 | 201.53% |
Krebs Biochemicals & Industries Limited | KREBSBIO | Drug Manufacturers-Specialty & Generic | 90.59 | 1.96B | -2.00% | n/a | -162.25% |
Bafna Pharmaceuticals Limited | BAFNAPH | Drug Manufacturers-Specialty & Generic | 79.14 | 1.89B | 658.33 | 30.17% | |
Aarey Drugs & Pharmaceuticals Limited | AAREYDRUGS | Drug Manufacturers-Specialty & Generic | 66.39 | 1.86B | -3.31% | 34.02 | 23.61% |
Lasa Supergenerics Limited | LASA | Drug Manufacturers-Specialty & Generic | 27.12 | 1.36B | -4.57% | n/a | 22.84% |
Ind-Swift Limited | INDSWFTLTD | Drug Manufacturers-Specialty & Generic | 23.81 | 1.29B | -1.37% | 3.23 | -146.78% |
Biofil Chemicals and Pharmaceuticals Limited | BIOFILCHEM | Drug Manufacturers-Specialty & Generic | 77.68 | 1.26B | -7.23% | 197.64 | 2.41% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 166.42 | 1.85B | -3.27% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 93.74 | 1.34B | -3.01% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.42 | 1.02B | -1.33% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.12 | 483.23M | 88.75 | 43.14% | |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.67 | 331.86M | -1.48% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 4.93 | 296.65M | -2.38% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 7.44 | 23.29 | Cheaper |
Ent. to Revenue | 1.58 | 12.02 | Cheaper |
PE Ratio | 14.11 | 47.84 | Cheaper |
Price to Book | 1.70 | 6.55 | Cheaper |
Dividend Yield | - | 0.59 | - |
Std. Deviation (3M) | 50.73 | 40.95 | Riskier |
Debt to Equity | 0.03 | 0.34 | Cheaper |
Debt to Assets | 0.03 | 0.17 | Cheaper |
Market Cap | 2.48B | 286.13B | Emerging |